Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase.

Human platelet-derived growth factor (PDGF) stimulated prostaglandin (PG) E2 synthesis in the cell cycle of Swiss 3T3 cells at two distinct time intervals, with a first plateau within 10 min and a second plateau within 2-4 h after addition of PDGF. At 4 h, the concentration of PGE2 in PDGF-stimulated cultures exceeded the quiescent control cells by a factor of 10-15. Quiescent cells incubated with up to 16 microM exogenous arachidonic acid (AA) synthesized only small amounts of PGE2. In contrast, 4 h after addition of PDGF, the concentration of PGE2 synthesized from exogenous AA exceeded that in quiescent cultures by a factor of 28. The effect of PDGF stimulation on PG synthesis from exogenous AA could not be explained by growth factor-mediated increase in the cellular free AA pool as shown in experiments using [14C]AA. PDGF also stimulated synthesis of PGI2 (prostacyclin), thromboxane, and PGF2 alpha from exogenous AA. While inhibition of protein synthesis by 10 micrograms/ml cycloheximide had no effect on the early increase in PGE2 synthesis, the second increase was completely prevented. Additionally, cycloheximide treatment at 6 h after PDGF stimulation resulted in rapid decline of PGE2 synthesis from exogenous AA. Quiescent cultures pretreated with 100 microM aspirin and stimulated by PDGF thereafter recovered from cyclooxygenase inhibition within 180 min. Our results suggest that phospholipase activation and resultant AA release is not sufficient to induce the burst of PG synthesis observed in PDGF-stimulated cells. Instead, PDGF stimulates PG synthesis by direct effects on the PG-synthesizing enzyme system, one involving a protein synthesis-independent mechanism and another that requires rapid translation of cyclooxygenase.

[1]  B. Kommerell,et al.  The phospholipase C diglyceride lipase pathway contributes to arachidonic acid release and prostaglandin E2 formation in platelet-derived growth factor stimulated Swiss 3T3 cells. , 1985, Advances in prostaglandin, thromboxane, and leukotriene research.

[2]  P. Majerus Arachidonate metabolism in vascular disorders. , 1983, The Journal of clinical investigation.

[3]  J. Hoak,et al.  Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase. , 1983, The Journal of clinical investigation.

[4]  R. Vandongen,et al.  Radioimmunoassay of prostaglandins and thromboxane B2 in extracted and unextracted urine and serum using an iodinated ligand. , 1983, Prostaglandins, leukotrienes, and medicine.

[5]  M. Waterfield,et al.  Platelet-derived growth factor elicits cyclic AMP accumulation in swiss 3T3 cells: Role of prostaglandin production , 1983, Cell.

[6]  K. Deschryver,et al.  Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells. , 1983, The Journal of clinical investigation.

[7]  E. Neufeld,et al.  Uptake and release of arachidonate by platelets. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

[8]  R. Michell,et al.  Inositol lipid metabolism in dividing and differentiating cells. , 1982, Cell calcium.

[9]  W. Powell Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. , 1982, Methods in enzymology.

[10]  R. Ross,et al.  Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. , 1981, The Journal of biological chemistry.

[11]  S. Cohen,et al.  Enhancement of calcium uptake and phosphatidylinositol turnover by epidermal growth factor in A-431 cells. , 1981, Biochemistry.

[12]  P. Cuatrecasas,et al.  Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets. , 1981, The Journal of biological chemistry.

[13]  M. Moskowitz,et al.  Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor , 1980, Nature.

[14]  R. Ross,et al.  Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor. , 1980, The Journal of biological chemistry.

[15]  W. Shier Serum stimulation of phospholipase A2 and prostaglandin release in 3T3 cells is associated with platelet-derived growth-promoting activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Cuatrecasas,et al.  Thrombin and bradykinin modulate prostaglandin synthetase independently of phospholipase. , 1980, Advances in prostaglandin and thromboxane research.

[17]  P. Majerus,et al.  Diglyceride lipase: a pathway for arachidonate release from human platelets. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. J. Blackwell,et al.  Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation , 1979, Nature.

[19]  S. Hammarström Prostaglandin production by normal and transformed 3T3 fibroblasts in cell culture. , 1977, European journal of biochemistry.

[20]  R. Michell Inositol phospholipids and cell surface receptor function. , 1975, Biochimica et biophysica acta.

[21]  R. Ross,et al.  Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .